These two specific products were not observed in NCI-A549 pulmonary adenocarcinoma cells harboring KRASG12S, NCI-H3122 pulmonary adenocarcinoma cells harboring EML4-ALK v1, and PDT-LUAD#5 lung tumoroids with BRAFG469A. This evidence concerns the gene ALK and medical procedure.